Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Contrast echocardiography in coronary artery diseased patients: effect of systemic and pulmonary artery pressures on left heart opacification after intravenous injection of Albunex.

Tytuł:
Contrast echocardiography in coronary artery diseased patients: effect of systemic and pulmonary artery pressures on left heart opacification after intravenous injection of Albunex.
Autorzy:
Geny B; Laboratoire d'Explorations Fonctionnelles du Système Circulatoire, Faculté de Médecine, Université Louis Pasteur, Strasbourg, France.
Piquard F
Muan B
Epailly E
Lambrechs M
Thiranos JC
Petit H
Eisenmann B
Haberey P
Źródło:
Coronary artery disease [Coron Artery Dis] 1997 Feb; Vol. 8 (2), pp. 77-81.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: London : Lippincott Williams & Wilkins
Original Publication: Philadelphia, Pa. : Current Science, c1990-
MeSH Terms:
Albumins/*administration & dosage
Blood Pressure/*physiology
Contrast Media/*administration & dosage
Coronary Disease/*diagnostic imaging
Coronary Vessels/*diagnostic imaging
Echocardiography/*methods
Pulmonary Wedge Pressure/*physiology
Adult ; Aged ; Cardiac Output ; Coronary Disease/physiopathology ; Female ; Heart Ventricles/diagnostic imaging ; Heart Ventricles/physiopathology ; Humans ; Injections, Intravenous ; Male ; Microspheres ; Middle Aged ; Radiography
Substance Nomenclature:
0 (Albumins)
0 (Albunex)
0 (Contrast Media)
Entry Date(s):
Date Created: 19970201 Date Completed: 19970820 Latest Revision: 20161124
Update Code:
20240104
PMID:
9211046
Czasopismo naukowe
Background: Contrast echocardiography is a useful tool for assessing repeatedly patients with coronary artery disease. Nevertheless, elevated pulmonary artery and systemic blood pressures likely to be associated with cardiac ischemia may limit the left ventricular opacification (LVO) because of the microspheres' sensitivity to pressure.
Objective: To determine the effects of systemic and pulmonary artery blood pressures on LVO.
Methods: We performed 55 intravenous injections (0.08 and 0.22 ml/kg) of a new transpulmonary contrast agent (Albunex), during two separated exposures, into 20 cardiac ischemic patients while monitoring invasively their cardiac indexes, and intracardiac, systemic, and pulmonary artery blood pressures. LVO was graded qualitatively from faint to full.
Results: A logistic model with the grade of LVO as the dependent variable and a selection from among the dose, exposure, right and left atrial blood pressures, systolic systemic and pulmonary artery blood pressures (ranges 94-208 and 14-45 mmHg, respectively), cardiac index, stroke index, and pulmonary and systemic vascular resistances as the explanatory variables demonstrated that increasing the dose gives an increasing probability of LVO (P = 0.02) and that increasing the pulmonary artery pressure reduces that probability (P = 0.006). A decreased cardiac index tended also to be associated with decreased LVO. The systemic blood pressure and the pulmonary and systemic vascular resistances had no statistically significant effect on the grade of LVO.
Conclusions: LVO after intravenous administration of Albunex is dose-dependent and limited by an elevated pulmonary artery pressure. These data suggest that one should use higher doses for cardiac ischemic patients with elevated pulmonary artery pressures and that use of Albunex has the potential to detect pulmonary hypertension in patients.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies